Enavate Sciences Gp, Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$351.5M
Q ending 2026-03-31
Prior quarter
$506.8M
Q ending 2025-12-31
Change
-30.6% QoQ · +164.8% YoY
Positions
7
reported holdings
Largest positions
All 7 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Sionna Therapeutics Inc | SION | Shares | $99.3M | 2.5M |
| Immunome Inc | IMNM | Shares | $79.0M | 3.6M |
| Zenas Biopharma Inc | ZBIO | Shares | $76.6M | 3.9M |
| Compass Therapeutics Inc | CMPX | Shares | $41.2M | 7.8M |
| Bridgebio Oncology Therapeut | BBOT | Shares | $23.5M | 2.6M |
| Upstream Bio Inc | UPB | Shares | $22.1M | 2.5M |
| Camp4 Therapeutics Corp | CAMP | Shares | $9.7M | 2.2M |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.